PL1865961T3 - Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego - Google Patents

Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego

Info

Publication number
PL1865961T3
PL1865961T3 PL06739956T PL06739956T PL1865961T3 PL 1865961 T3 PL1865961 T3 PL 1865961T3 PL 06739956 T PL06739956 T PL 06739956T PL 06739956 T PL06739956 T PL 06739956T PL 1865961 T3 PL1865961 T3 PL 1865961T3
Authority
PL
Poland
Prior art keywords
treatment
famciclovir
herpes labialis
recurrent herpes
day
Prior art date
Application number
PL06739956T
Other languages
English (en)
Polish (pl)
Inventor
Stephan Billstein
Robert Charnas
Spotswood L Spruance
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/US2006/011498 external-priority patent/WO2006105216A1/en
Publication of PL1865961T3 publication Critical patent/PL1865961T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL06739956T 2005-03-30 2006-03-29 Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego PL1865961T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66653605P 2005-03-30 2005-03-30
PCT/US2006/011498 WO2006105216A1 (en) 2005-03-30 2006-03-29 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
EP06739956A EP1865961B1 (en) 2005-03-30 2006-03-29 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment

Publications (1)

Publication Number Publication Date
PL1865961T3 true PL1865961T3 (pl) 2012-07-31

Family

ID=36829888

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06739956T PL1865961T3 (pl) 2005-03-30 2006-03-29 Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego

Country Status (15)

Country Link
US (4) US20100298353A1 (enExample)
EP (2) EP2363131A1 (enExample)
JP (3) JP2008534603A (enExample)
KR (1) KR101312820B1 (enExample)
CN (1) CN101678028A (enExample)
AT (1) ATE545419T1 (enExample)
AU (3) AU2006230269A1 (enExample)
BR (1) BRPI0609793A2 (enExample)
CA (1) CA2602641A1 (enExample)
ES (1) ES2382664T3 (enExample)
PL (1) PL1865961T3 (enExample)
PT (1) PT1865961E (enExample)
RU (2) RU2007139762A (enExample)
TW (1) TW200716124A (enExample)
WO (1) WO2006105194A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
DE3671227D1 (de) 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
GB8628826D0 (en) 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
RU2179849C2 (ru) * 1999-07-27 2002-02-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения рецидивирующего генитального герпеса у женщин
RU2178699C1 (ru) * 2001-04-04 2002-01-27 Змызгова Анна Васильевна Способ лечения герпесовирусных инфекций, включающий озонотерапию
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Also Published As

Publication number Publication date
AU2010201834A1 (en) 2010-05-27
US20100298353A1 (en) 2010-11-25
US20120329814A1 (en) 2012-12-27
JP2013049687A (ja) 2013-03-14
KR101312820B1 (ko) 2013-09-27
KR20080004535A (ko) 2008-01-09
JP2008534603A (ja) 2008-08-28
ATE545419T1 (de) 2012-03-15
RU2007139762A (ru) 2009-05-10
AU2006230291A8 (en) 2013-10-24
WO2006105194A2 (en) 2006-10-05
EP2363131A1 (en) 2011-09-07
EP1865961B1 (en) 2012-02-15
RU2007139758A (ru) 2009-05-10
WO2006105194A3 (en) 2006-12-21
RU2432951C2 (ru) 2011-11-10
BRPI0609793A2 (pt) 2010-04-27
JP2015163614A (ja) 2015-09-10
AU2006230269A1 (en) 2006-10-05
US20150005324A1 (en) 2015-01-01
AU2006230291A1 (en) 2006-10-05
TW200716124A (en) 2007-05-01
PT1865961E (pt) 2012-05-22
CA2602641A1 (en) 2006-10-05
ES2382664T3 (es) 2012-06-12
JP6018473B2 (ja) 2016-11-02
CN101678028A (zh) 2010-03-24
US20120088781A1 (en) 2012-04-12
AU2010201834B2 (en) 2012-04-19
EP1865961A1 (en) 2007-12-19

Similar Documents

Publication Publication Date Title
FI7594U1 (fi) Absorptiokappale kiinitettäväksi ihmiskehoon
SI1613350T1 (sl) Zdravljenje avtoimunske bolezni pri bolniku z neustreznim odzivom na inhibitor TNF-alfa
PL2305711T3 (pl) Sposoby leczenia bólu w zapaleniu kości i stawów przez podawanie antagonisty czynnika wzrostu nerwów oraz zawierających go kompozycji
WO2008043052A3 (en) Human antibodies neutralizing human metapneumovirus
WO2005053607A3 (en) Method for preventing hepatic encephalopathic episodes
NZ577393A (en) Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction
CY1111390T1 (el) Μεθοδος θεραπευτικης αγωγης καρκινου
PL1603915T3 (pl) Podstawione pochodne 8-pirydynylo-dihydrospiro-cykloalkilo-pirymido-1,2-a-pirymidyn-6-onu i 8-pirymidynylo-dihydrospiro-cykloalkilo-pirymido-1,2-a-pirymidyn-6-onu oraz ich zastosowanie przeciwko chorobom neurodegeneracyjnym
IL183447A0 (en) Substituted pteridines for treating inflammatory diseases
WO2006138709A3 (en) Lkktet and/or lkktnt peptide compositions and methods
WO2006128022A3 (en) Solid compositions and methods for treating middle-of-the night insomnia
SI1900362T1 (sl) Derivati alfa-aminoamida, uporabni pri zdravljenju odvisnosti
EP1660010A4 (en) COMPOSITIONS AND METHODS FOR RE-ESTABLISHING SENSITIVITY TO ANTAGONIST TREATMENT OF HER2
WO2007109093A3 (en) Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof
FR2884826B1 (fr) Composition de polissage et procede de polissage l'utilisant
WO2006033795A3 (en) Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
EP1550442A4 (en) COMPOSITION FOR PREVENTION / TREATMENT OF THE IMPACT OF CLINICAL SYMPTOMS IN DISEASES EMBODIED BY MITOCHONDRIENE DYSFUNCTION
PL1865961T3 (pl) Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego
SI1891961T1 (sl) Uporaba 5'-metiltioadenozina (MTA) za preprečevanje in/ali zdravljenje avtoimunske bolezni in/ali transplantacijske zavrnitve
TW200742580A (en) Methods for treating nephrolithiasis
SI1362590T1 (sl) Uporaba ciklobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje
WO2005077356A3 (en) Glycine and/or for use in cartilage affecting conditions
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
UY29532A1 (es) Derivados del ácido 6,7-dihidro-5h-imidazo(1,2-a)imidazol-3-sulfónico
AU2003244978A8 (en) Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions